Christopher John De Bakker

Title: The Innovative Contributions of Christopher John De Bakker

Introduction

Christopher John De Bakker is a notable inventor based in Margate, Australia, recognized for his groundbreaking work in the field of biochemistry. With two patents to his name, De Bakker's contributions particularly focus on chaperonin proteins, which play a crucial role in cellular functions.

Latest Patents

De Bakker's latest patents showcase his innovative thinking. The first patent, titled "Modified Cpn10 and PRR Signalling," relates to isolated Cpn10 polypeptides that have an increased affinity for a PRR ligand compared to the standard Ala Cpn10 polypeptide. This invention further extends to modified chaperonin 10 polypeptides, nucleic acids encoding these polypeptides, and various compositions that utilize them. The second patent, "Chaperonin 10 Variants," addresses N-terminal variants of chaperonin 10, targeting enhancements in immunomodulatory capacities and binding affinities for pathogen-associated and damage-associated molecular patterns.

Career Highlights

Christopher John De Bakker is currently employed at Cbio Limited, where he applies his expertise to facilitate advancements in biochemical research and applications. His commitment and innovative spirit have established him as a valuable asset in his field.

Collaborations

Throughout his career, De Bakker has collaborated with esteemed colleagues, including Dean Jason Naylor and Richard James Brown. These partnerships have fueled his innovative projects and contributed to the successful development of his patents.

Conclusion

With his impactful inventions and collaborations, Christopher John De Bakker continues to contribute to the scientific community, pushing the boundaries of our understanding of chaperonin proteins. His work not only reflects his dedication as an inventor but also highlights the ongoing importance of innovation in the biochemistry sphere.